NMPA registration: cost and timeline
Registration is not a fee you pay and a queue you wait in. It is a sequence in which one stage cannot start until the previous one closes, and the calendar time is set by the slowest stage rather than by the authority.
Two routes, decided by risk class
A class II device made in China is registered with the provincial medical products administration of the province where it is manufactured. A class III device goes to the national administration. The route is not a preference; it follows the classification, and the front of the certificate number shows which route was taken.
Class I devices are filed rather than registered and do not go through the same review. That is why a supplier saying the product is registered should be asked which class it is in, because the answer changes what the document in front of you is supposed to be.
Where the calendar time actually goes
Testing
The product is tested against its technical requirements at a qualified laboratory. This stage runs before the application and its duration depends on the test items, the laboratory queue and whether the first round passes. A failed item restarts that test, not the whole programme.
Clinical evaluation
Most dressing and gel products fall within the catalogue of devices exempt from clinical trials, and the work is then a literature-based clinical evaluation rather than a study. Products outside that catalogue face a study, which is a different order of time and cost entirely.
Technical review
The authority reviews the dossier against the deadline published for its class, counted in working days rather than calendar days. If the reviewer issues a deficiency notice, the clock pauses while you answer and the review period restarts when the answer is accepted. Deficiency rounds are the single largest source of variance.
Quality system inspection
The manufacturing site is inspected against the quality system requirements for the product being registered. For a site that already holds inspections for similar products this is a shorter exercise than for a first submission, but it is scheduled on the authority's calendar and cannot be pulled forward by paying more.
What the cost is made of
A registration programme has five cost lines, and only one of them is the official fee. Anyone quoting a single number without saying which of these it covers is quoting a number you cannot compare.
- Type testing at a qualified laboratory, priced per test item and per sample.
- The clinical evaluation, whether literature-based or a study, which is the largest variable line.
- Preparation of the technical dossier, including the technical requirements document that the testing is written against.
- The quality system documentation and the inspection itself, including the cost of closing findings.
- Agent or consultancy fees, if a third party files on the holder's behalf, and translation or notarisation where the destination market needs it.
This page does not put a figure on any of them. Registration cost for a dressing and for a gel in the same class can differ by a multiple once testing items and the clinical route are counted, and a number published here would be wrong for most readers and right for none. What can be compared across suppliers is the scope: which of the five lines the quote includes, and who carries a re-test if an item fails.
Five reasons a schedule doubles
- The product is classified higher than the supplier expected, which moves it to a different authority and a different review depth.
- The technical requirements document was written loosely, so testing has to be repeated against a corrected version.
- The product is outside the exempt-from-clinical-trial catalogue and nobody checked before quoting.
- Two deficiency rounds instead of one, each of which restarts the review period.
- The manufacturing site is inspected for the first time for that product family, and findings have to be closed before the certificate issues.
None of these is unusual, and all five are visible before the programme starts to someone who reads the catalogue and the classification rules. That is the difference between a quoted schedule and an assessed one.
What a buyer should ask instead of a date
Asking when the certificate will arrive invites an optimistic answer, because the person answering is not the person who will be waiting on the laboratory. Three questions get a more useful reply.
- Which class is this product in, and which authority will review it?
- Is it inside or outside the catalogue exempt from clinical trials, and what evidence supports that answer?
- Has this site already been inspected for this product family, and can I see the inspection outcome?
Answers to those three tell you more about your delivery date than any promised month. They also tell you whether the person quoting understands the route, which is the thing you are really buying when you buy from a registered manufacturer.
Where to go next
- Medical device manufacturing in China — How registration sits inside a manufacturing programme, from enquiry to first order.
- Medical devices — The device range with the certificate numbers that are already held for it.
- Class II vs class III medical devices in China — What the class decides, and how it shows up in the certificate.
- Certifications — The registrations this site already holds, which is the shortest route to an existing product.
